Zekavat et al. [25] demonstrated that PAD-CHIP carriers are characterized in older males who were previous smokers and have a history of CAD, hypertension, and hyperlipidemia, indicating a common vascular bed damage pathway as reported earlier [40,41]. Here, STUB1 is linked to hypertensive disorder.